Study Identifies Heart Risks in Glaxo's Avandia

Airtime: Mon. Feb. 22 2010 | ET
Dr. Steven Nissen, of the Cleveland Clinic, authored a controversial study identifying heart risks in GlaxoSmithKline’s Avandia diabetes drug. He talks to CNBC’s Mike Huckman.

Leave a Reply

Your email address will not be published. Required fields are marked *